Graves' disease is an autoimmune disorder that primarily affects the thyroid gland, leading to an overproduction of thyroid hormones. It is characterized by several distinctive features, including:
A diffuse toxic goiter refers to a diffusely hyperplastic thyroid gland that is excessively overproducing thyroid hormones. A diffuse toxic goiter refers to a diffusely hyperplastic thyroid gland that is excessively overproducing thyroid hormones. As a result, the thyroid gland becomes visibly enlarged. The goiter is typically diffuse, meaning it affects the entire thyroid gland rather than being localized to one specific area.
A rare manifestation of Graves disease characterized by the periosteal new bone formation and digital clubbing. It affects about 0.3% of patients with Graves’ disease and often occurs in euthyroid and hypothyroid patients within weeks to many years after treatment of original thyrotoxicosis (Bartalena & Fatourechi, 2014). It is almost always associated with thyroid ophthalmopathy and dermopathy (Fatourechi et al., 2002). It manifests as soft tissue swelling with digital clubbing, and periosteal reaction of the extremities.
Graves' disease is an autoimmune disorder, meaning the immune system mistakenly attacks the body's tissues. It is often associated with the presence of specific antibodies called thyroid-stimulating immunoglobulins (TSIs) or thyroid receptor antibodies (TRAb). These antibodies stimulate the thyroid gland, leading to increased hormone production.